P016: Results of an open-label, single-center, clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis I subjects

Bibliographic Details
Main Authors: Curtis Gravance, Drago Bratkovic, David Ketteridge, Michael Imperiale, Ravi Krishnan, Divya Navuru
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Genetics in Medicine Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2949774423000262
_version_ 1797342097671454720
author Curtis Gravance
Drago Bratkovic
David Ketteridge
Michael Imperiale
Ravi Krishnan
Divya Navuru
author_facet Curtis Gravance
Drago Bratkovic
David Ketteridge
Michael Imperiale
Ravi Krishnan
Divya Navuru
author_sort Curtis Gravance
collection DOAJ
first_indexed 2024-03-08T10:28:29Z
format Article
id doaj.art-57591d9d7aea40debe7953ba11995d06
institution Directory Open Access Journal
issn 2949-7744
language English
last_indexed 2024-03-08T10:28:29Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Genetics in Medicine Open
spelling doaj.art-57591d9d7aea40debe7953ba11995d062024-01-27T07:03:40ZengElsevierGenetics in Medicine Open2949-77442023-01-0111100026P016: Results of an open-label, single-center, clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis I subjectsCurtis Gravance0Drago Bratkovic1David Ketteridge2Michael Imperiale3Ravi Krishnan4Divya Navuru5Paradigm Biopharmaceuticals LtdWomen’s and Children’s Hospital, South AustraliaWomen’s and Children’s Hospital, South AustraliaParadigm Biopharmaceuticals LtdParadigm Biopharmaceuticals LtdParadigm Biopharmaceuticals Ltdhttp://www.sciencedirect.com/science/article/pii/S2949774423000262
spellingShingle Curtis Gravance
Drago Bratkovic
David Ketteridge
Michael Imperiale
Ravi Krishnan
Divya Navuru
P016: Results of an open-label, single-center, clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis I subjects
Genetics in Medicine Open
title P016: Results of an open-label, single-center, clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis I subjects
title_full P016: Results of an open-label, single-center, clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis I subjects
title_fullStr P016: Results of an open-label, single-center, clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis I subjects
title_full_unstemmed P016: Results of an open-label, single-center, clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis I subjects
title_short P016: Results of an open-label, single-center, clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis I subjects
title_sort p016 results of an open label single center clinical study evaluating the safety and tolerability of pentosan polysulfate sodium in mucopolysaccharidosis i subjects
url http://www.sciencedirect.com/science/article/pii/S2949774423000262
work_keys_str_mv AT curtisgravance p016resultsofanopenlabelsinglecenterclinicalstudyevaluatingthesafetyandtolerabilityofpentosanpolysulfatesodiuminmucopolysaccharidosisisubjects
AT dragobratkovic p016resultsofanopenlabelsinglecenterclinicalstudyevaluatingthesafetyandtolerabilityofpentosanpolysulfatesodiuminmucopolysaccharidosisisubjects
AT davidketteridge p016resultsofanopenlabelsinglecenterclinicalstudyevaluatingthesafetyandtolerabilityofpentosanpolysulfatesodiuminmucopolysaccharidosisisubjects
AT michaelimperiale p016resultsofanopenlabelsinglecenterclinicalstudyevaluatingthesafetyandtolerabilityofpentosanpolysulfatesodiuminmucopolysaccharidosisisubjects
AT ravikrishnan p016resultsofanopenlabelsinglecenterclinicalstudyevaluatingthesafetyandtolerabilityofpentosanpolysulfatesodiuminmucopolysaccharidosisisubjects
AT divyanavuru p016resultsofanopenlabelsinglecenterclinicalstudyevaluatingthesafetyandtolerabilityofpentosanpolysulfatesodiuminmucopolysaccharidosisisubjects